AIM EXAM REASONING

Question:

During induction of anesthesia, a non-depolarizing blocker is administered. The patient first develops weakness of eye movements and facial muscles while diaphragmatic movement remains present. Which explanation best accounts for this pattern?

Correct Answer: Small rapidly moving muscles are more sensitive to blockade

Explanation: Neuromuscular blockade commonly affects the eyes, face and jaw before the trunk and diaphragm. The diaphragm is among the last muscles to become paralyzed.

Question:

At the end of surgery, a patient begins moving the diaphragm and limbs after neuromuscular blockade. Weakness of the facial and upper-airway muscles remains. Which principle best explains this finding?

Correct Answer: Recovery generally occurs in the reverse order of paralysis

Explanation: The diaphragm and larger muscles may recover before small facial and upper-airway muscles. Visible limb movement therefore does not confirm complete neuromuscular recovery.

Question:

A patient undergoing electroconvulsive therapy receives a short-acting skeletal-muscle relaxant before electrical stimulation. What is the main purpose of this drug?

Correct Answer: To reduce musculoskeletal injury from contractions

Explanation: Brief neuromuscular blockade reduces the force of peripheral muscle contractions during electroconvulsive therapy and lowers the risk of fractures or soft-tissue injury.

Question:

A conscious patient in intensive care receives a neuromuscular blocker to improve mechanical ventilation. He becomes completely immobile but remains tachycardic and appears distressed. Which accompanying treatment was most likely inadequate?

Correct Answer: Sedation and analgesia

Explanation: Neuromuscular blockers cause paralysis without unconsciousness or pain relief. Adequate sedation and analgesia must be provided independently.

Question:

A patient with severe bronchial hyperreactivity requires an intermediate-acting non-depolarizing blocker. The anesthetist wants to minimize histamine-mediated bronchospasm. Which drug is the most appropriate choice?

Correct Answer: Cisatracurium

Explanation: Cisatracurium is related to atracurium but produces less histamine release, making it preferable when bronchospasm or hypotension is a concern.

Question:

A patient receives rocuronium for rapid tracheal intubation. At the end of a short operation, the anesthetist wants rapid reversal without increasing acetylcholine at muscarinic receptors. Which intervention best meets this objective?

Correct Answer: Sugammadex

Explanation: Sugammadex binds free rocuronium molecules in plasma, reducing their availability at the neuromuscular junction without increasing acetylcholine.

Question:

After sugammadex is given to reverse rocuronium, the plasma concentration of unbound rocuronium falls rapidly. What happens next at the neuromuscular junction?

Correct Answer: Rocuronium moves away from Nₘ receptors into plasma

Explanation: Encapsulation of circulating rocuronium creates a concentration gradient that draws drug away from the neuromuscular junction, allowing acetylcholine to activate Nₘ receptors again.

Question:

A patient receiving magnesium therapy develops unexpectedly profound weakness after a standard dose of a non-depolarizing blocker. Which combined effect of magnesium best explains the enhanced paralysis?

Correct Answer: Reduced transmitter release and reduced muscle responsiveness

Explanation: Magnesium decreases acetylcholine release from motor nerves and reduces postsynaptic muscle responsiveness, thereby strengthening neuromuscular blockade.

Question:

A patient with renal impairment receives a neuromuscular blocker that is primarily eliminated by the kidneys. Recovery is markedly delayed. Which pharmacokinetic change most directly explains this outcome?

Correct Answer: Reduced drug clearance

Explanation: Impaired renal elimination allows the blocker to remain in the circulation longer, prolonging receptor occupancy and neuromuscular paralysis.

Question:

During train-of-four monitoring after a non-depolarizing blocker, the first muscular response is stronger than the fourth. What does this pattern indicate?

Correct Answer: Residual non-depolarizing blockade

Explanation: Progressive weakening of successive responses is called fade and is characteristic of non-depolarizing blockade or a Phase II depolarizing block.

Question:

A patient receives a single dose of succinylcholine. During the initial paralysis, all four responses to train-of-four stimulation are reduced to a similar degree without fade. Which state is most likely present?

Correct Answer: Phase I depolarizing block

Explanation: Phase I succinylcholine block produces uniform depression of responses without the characteristic fade seen with non-depolarizing or Phase II blockade.

Question:

A patient has a normal motor-nerve action potential and normal acetylcholine release, but a non-depolarizing blocker is present at the motor end plate. Which event is most directly prevented?

Correct Answer: Adequate depolarization of the motor end plate

Explanation: Competitive occupation of Nₘ receptors prevents acetylcholine from opening enough receptor channels to generate a threshold end-plate potential.

Question:

A patient develops brief generalized muscle contractions immediately after a depolarizing blocker is administered. Which cellular event produces these initial contractions?

Correct Answer: Initial activation and depolarization of motor end plates

Explanation: Succinylcholine first activates Nₘ receptors and causes contraction. Persistent depolarization then inactivates sodium channels and produces paralysis.

Question:

A child receives repeated doses of succinylcholine during a procedure and develops marked slowing of the heart rate. Which adverse effect is being demonstrated?

Correct Answer: Dose-related bradycardia

Explanation: Repeated succinylcholine administration may produce bradycardia, particularly in children, because of cholinergic cardiac effects.

Question:

A patient with painful back spasm is prescribed diazepam. His symptoms improve, but he becomes drowsy and unsteady. Which pharmacological action accounts for both effects?

Correct Answer: Enhancement of GABAₐ-mediated inhibition

Explanation: Diazepam enhances GABAₐ receptor activity, reducing muscle spasm but also causing sedation, impaired coordination and dependence risk.

Question:

A patient taking a centrally acting muscle relaxant combines it with another central nervous system depressant and develops excessive sedation and slow breathing. Which prescribed drug is most likely to contribute to this interaction?

Correct Answer: Diazepam

Explanation: Diazepam is a central nervous system depressant. Its sedative and respiratory-depressant effects may be enhanced by other depressant drugs.

Question:

A patient receiving long-term oral dantrolene for severe spasticity develops fatigue, proximal weakness and elevated liver enzymes. Which property of the drug explains the muscular symptoms?

Correct Answer: It reduces calcium available for muscle contraction

Explanation: Dantrolene reduces sarcoplasmic-reticulum calcium release. This decreases actin–myosin interaction and may produce clinically significant muscle weakness.

Question:

During an anesthetic emergency, active cooling lowers the patient’s temperature, but muscle rigidity, carbon dioxide production and acidosis continue to worsen. Why is dantrolene still required?

Correct Answer: Cooling does not correct uncontrolled intracellular calcium release

Explanation: Cooling treats the elevated temperature, whereas dantrolene treats the primary defect by reducing excessive calcium release and skeletal-muscle hypermetabolism.

Question:

A patient with a family history of an anesthetic-related hypermetabolic crisis requires surgery. Which anesthetic plan best reduces the risk of triggering the same reaction?

Correct Answer: Avoid volatile anesthetics and succinylcholine

Explanation: Volatile inhalational anesthetics and succinylcholine are major triggers of malignant hyperthermia in genetically susceptible patients.

Question:

A patient previously experienced prolonged paralysis after succinylcholine but had no muscle rigidity, hyperthermia, acidosis or hyperkalemia. Which interpretation best distinguishes this event from malignant hyperthermia?

Correct Answer: The reaction reflects delayed succinylcholine metabolism

Explanation: Isolated prolonged apnea without rigidity or hypermetabolism suggests reduced butyrylcholinesterase activity, whereas malignant hyperthermia is an uncontrolled calcium-release syndrome.